{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T22:07:53Z","timestamp":1778018873282,"version":"3.51.4"},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":162,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Opioid use has negative effects on immune responses and may impair immune reconstitution in persons living with HIV (PLWH) infection undergoing antiretroviral treatment (ART). The effects of treatment with \u03bc opioid receptor (MOR) agonists (e.g., methadone, MET) and antagonists (e.g., naltrexone, NTX) on immune reconstitution and immune activation in ART-suppressed PLWH have not been assessed in-depth. We studied the effects of methadone or naltrexone on measures of immune reconstitution and immune activation in a cross-sectional community cohort of 30 HIV-infected individuals receiving suppressive ART and medications for opioid use disorder (MOUD) (12 MET, 8 NTX and 10 controls). Plasma markers of inflammation and immune activation were measured using ELISA, Luminex, or Simoa. Plasma IgG glycosylation was assessed using capillary electrophoresis. Cell subsets and activation were studied using whole blood flow cytometry. Individuals in the MET group, but no in the NTX group, had higher plasma levels of inflammation and immune activation markers than controls. These markers include soluble CD14 (an independent predictor of morbidity and mortality during HIV infection), proinflammatory cytokines, and proinflammatory IgG glycans. This effect was independent of time on treatment. Our results indicate that methadone-based MOUD regimens may sustain immune activation and inflammation in ART-treated HIV-infected individuals. Our pilot study provides the foundation and rationale for future longitudinal functional studies of the impact of MOUD regimens on immune reconstitution and residual activation after ART-mediated suppression.<\/jats:p>","DOI":"10.1002\/jlb.4a1221-678rr","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T08:14:12Z","timestamp":1659428052000},"page":"733-744","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Methadone use is associated with increased levels of sCD14, immune activation, and inflammation during suppressed HIV infection"],"prefix":"10.1093","volume":"112","author":[{"given":"Livio","family":"Azzoni","sequence":"first","affiliation":[{"name":"Vaccine and Immunotherapy Center, The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila B","family":"Giron","sequence":"additional","affiliation":[{"name":"Vaccine and Immunotherapy Center, The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surya","family":"Vadrevu","sequence":"additional","affiliation":[{"name":"Vaccine and Immunotherapy Center, The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine - University of PA , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linden","family":"Lalley-Chareczko","sequence":"additional","affiliation":[{"name":"Philadelphia FIGHT Community Health Centers , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Hiserodt","sequence":"additional","affiliation":[{"name":"Philadelphia FIGHT Community Health Centers , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Fair","sequence":"additional","affiliation":[{"name":"Vaccine and Immunotherapy Center, The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Lynn","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine - University of PA , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Trooskin","sequence":"additional","affiliation":[{"name":"Philadelphia FIGHT Community Health Centers , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karam","family":"Mounzer","sequence":"additional","affiliation":[{"name":"Philadelphia FIGHT Community Health Centers , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdel-Mohsen","sequence":"additional","affiliation":[{"name":"Vaccine and Immunotherapy Center, The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis J","family":"Montaner","sequence":"additional","affiliation":[{"name":"Vaccine and Immunotherapy Center, The Wistar Institute , Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/M18-2124","article-title":"Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data","volume":"170","author":"Schranz","year":"2019","journal-title":"Ann Intern Med"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/jamainternmed.2018.6101","article-title":"Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV","volume":"179","author":"Edelman","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2023032107574022700_","first-page":"109","article-title":"Primary care for persons who inject drugs","volume":"99","author":"Visconti","year":"2019","journal-title":"Am Fam Physician"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-019-02019-3","article-title":"The US opioid epidemic is driving a spike in infectious diseases","volume":"571","author":"Reardon","year":"2019","journal-title":"Nature"},{"key":"2023032107574022700_","first-page":"153","article-title":"Alterations of immune functions in heroin addicts","volume":"13","author":"Zaki","year":"2006","journal-title":"Egypt J Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0034-7094(12)70169-1","article-title":"Opioids and the immune system: clinical relevance","volume":"62","author":"Garcia","year":"2012","journal-title":"Rev Bras Anestesiol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/jmv.24419","article-title":"Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients","volume":"88","author":"Zhu","year":"2016","journal-title":"J Med Virol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/bja\/aet153","article-title":"Opioids and immune modulation: more questions than answers","volume":"111","author":"Al-Hashimi","year":"2013","journal-title":"Br J Anaesth"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1189\/jlb.0710402","article-title":"Opioid-induced chemokine expression requires NF-kappaB activity: the role of PKCzeta","volume":"89","author":"Happel","year":"2011","journal-title":"J Leukoc Biol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneuroim.2003.11.006","article-title":"Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT","volume":"148","author":"Saurer","year":"2004","journal-title":"J Neuroimmunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","article-title":"Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections","volume":"6","author":"Roy","year":"2011","journal-title":"J Neuroimmune Pharmacol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00726-011-1163-0","article-title":"Role of the mu-opioid receptor in opioid modulation of immune function","volume":"45","author":"Ninkovic","year":"2013","journal-title":"Amino Acids"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1074\/mcp.M111.016121","article-title":"Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels","volume":"11","author":"Brown","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"2023032107574022700_","article-title":"Morphine induces bacterial translocation in mice by compromising intestinal barrier function in a TLR-dependent manner","volume":"8","author":"Meng","year":"2013","journal-title":"PLoS One"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(89)92509-9","article-title":"Opioid inhibition of neurally mediated mucus secretion in human bronchi","volume":"1","author":"Rogers","year":"1989","journal-title":"Lancet"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/mi.2016.9","article-title":"Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation","volume":"9","author":"Banerjee","year":"2016","journal-title":"Mucosal Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0192623316679898","article-title":"Gut homeostasis, microbial dysbiosis, and opioids","volume":"45","author":"Wang","year":"2017","journal-title":"Toxicol Pathol"},{"key":"2023032107574022700_","article-title":"Impact of intravenous heroin and HIV on gut integrity and immune activation","volume-title":"Conference on Retroviruses and Opportunistic Infecitons","author":"Hileman","year":"2020"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-6105.1000257","article-title":"Behavioural, mucosal and systemic immune parameters in HIV-infected and uninfected injection drug users","volume":"6","author":"Mehandru","year":"2015","journal-title":"J Addict Res Ther"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3389\/fimmu.2020.01455","article-title":"Toll-like receptor 4 (TLR4)\/opioid receptor pathway crosstalk and impact on opioid analgesia, immune function, and gastrointestinal motility","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","article-title":"The role of opioid receptors in immune system function","volume":"10","author":"Eisenstein","year":"2019","journal-title":"Front Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2018.11.034","article-title":"Medicaid trends in prescription opioid and non-opioid use by HIV status","volume":"197","author":"Canan","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/00002030-200209270-00002","article-title":"Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease","volume":"16","author":"Valdez","year":"2002","journal-title":"Aids"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/infdis\/jir507","article-title":"Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells","volume":"204","author":"Lederman","year":"2011","journal-title":"J Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/605890","article-title":"Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells","volume":"200","author":"French","year":"2009","journal-title":"J Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11904-012-0118-8","article-title":"HIV and inflammation: mechanisms and consequences","volume":"9","author":"Hunt","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.4049\/jimmunol.181.4.2887","article-title":"Impaired restoration of plasmacytoid dendritic cells in HIV-1-infected patients with poor CD4 T cell reconstitution is associated with decrease in capacity to produce IFN-alpha but not proinflammatory cytokines","volume":"181","author":"Sachdeva","year":"2008","journal-title":"J Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.4049\/jimmunol.168.9.4796","article-title":"Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals","volume":"168","author":"Chehimi","year":"2002","journal-title":"J Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/QAD.0b013e328351f756","article-title":"HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy","volume":"26","author":"Hearps","year":"2012","journal-title":"Aids"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar6759","article-title":"CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells","volume":"10","author":"Abdel-Mohsen","year":"2018","journal-title":"Sci Transl Med"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clim.2006.04.570","article-title":"Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function","volume":"120","author":"Fernandez","year":"2006","journal-title":"Clin Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1086\/504718","article-title":"Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA","volume":"194","author":"Goicoechea","year":"2006","journal-title":"J Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2334-11-43","article-title":"High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort","volume":"11","author":"Nakanjako","year":"2011","journal-title":"BMC Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/infdis\/jir214","article-title":"Soluble CD163 made by monocyte\/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy","volume":"204","author":"Burdo","year":"2011","journal-title":"J Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients","volume":"204","author":"Burdo","year":"2011","journal-title":"J Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1189\/jlb.5AB0915-406R","article-title":"Antiretroviral therapy in HIV-1-infected individuals with CD4 count below 100 cells\/mm3 results in differential recovery of monocyte activation","volume":"100","author":"Patro","year":"2016","journal-title":"J Leukoc Biol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1377\/hlthaff.2011.0663","article-title":"The urgency of providing comprehensive and integrated treatment for substance abusers with HIV","volume":"30","author":"Volkow","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"2023032107574022700_","volume-title":"Three cents a day is not enough: resourcing HIV-related harm reduction on a global basis","author":"Stimson","year":"2010"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.intimp.2018.11.047","article-title":"Methadone therapy modulate the dendritic cells of heroin addicts","volume":"66","author":"Akbari","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4049\/jimmunol.1900862","article-title":"Chronic methadone use alters the CD8(+) T cell phenotype in vivo and modulates its responsiveness ex vivo to opioid receptor and TCR stimuli","volume":"204","author":"Mazahery","year":"2020","journal-title":"J Immunol"},{"key":"2023032107574022700_","first-page":"192","article-title":"Immune function in heroin addicts and former heroin addicts in treatment: pre- and post-AIDS epidemic","volume":"96","author":"Kreek","year":"1990","journal-title":"NIDA Res Monogr"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1360-0443.1993.tb00809.x","article-title":"The effects of methadone on immune function among injecting drug users: a review","volume":"88","author":"McLachlan","year":"1993","journal-title":"Addiction"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","article-title":"Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)","volume":"28","author":"Hutchinson","year":"2008","journal-title":"Eur J Neurosci"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fimmu.2017.00809","article-title":"Naltrexone inhibits IL-6 and tnfalpha production in human immune cell subsets following stimulation with ligands for intracellular toll-like receptors","volume":"8","author":"Cant","year":"2017","journal-title":"Front Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/bph.13394","article-title":"Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4","volume":"173","author":"Wang","year":"2016","journal-title":"Br J Pharmacol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12967-018-1427-5","article-title":"Low dose Naltrexone for induction of remission in inflammatory bowel disease patients","volume":"16","author":"Lie","year":"2018","journal-title":"J Transl Med"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"16359","DOI":"10.1074\/jbc.RA120.013484","article-title":"Low-dose naltrexone rescues inflammation and insulin resistance associated with hyperinsulinemia","volume":"295","author":"Choubey","year":"2020","journal-title":"J Biol Chem"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines5020016","article-title":"Reduced pro-inflammatory cytokines after eight weeks of low-dose naltrexone for fibromyalgia","volume":"5","author":"Parkitny","year":"2017","journal-title":"Biomedicines"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11481-020-09959-y","article-title":"Effect of opioid use on immune activation and HIV persistence on ART","volume":"15","author":"Azzoni","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/QAD.0000000000002476","article-title":"Plasma and antibody glycomic biomarkers of time to HIV rebound and viral setpoint","volume":"34","author":"Giron","year":"2020","journal-title":"AIDS"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/COH.0b013e32835c7134","article-title":"Soluble biomarkers of HIV transmission, disease progression and comorbidities","volume":"8","author":"Leeansyah","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-407707-2.00002-3","article-title":"Residual immune dysregulation syndrome in treated HIV infection","volume":"119","author":"Lederman","year":"2013","journal-title":"Adv Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/427877","article-title":"Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection","volume":"40","author":"Mildvan","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2009.05.008","article-title":"Neopterin, a prognostic marker in human malignancies","volume":"287","author":"Sucher","year":"2010","journal-title":"Cancer Lett"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000236491","article-title":"Neopterin, biochemistry and clinical use as a marker for cellular immune reactions","volume":"101","author":"Fuchs","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"2023032107574022700_","first-page":"1297","article-title":"Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects","volume":"6","author":"Di Franco","year":"1993","journal-title":"J Acquir Immune Defic Syndr (1988)"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2019.00465","article-title":"Circulating LPS and (1\u21923)-beta-D-Glucan: a Folie a Deux contributing to HIV-associated immune activation","volume":"10","author":"Ramendra","year":"2019","journal-title":"Front Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/myc.12797","article-title":"Use of (1\u21923)-beta-d-glucan for diagnosis and management of invasive mycoses in HIV-infected patients","volume":"61","author":"Farhour","year":"2018","journal-title":"Mycoses"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055038","article-title":"Kinetics of microbial translocation markers in patients on efavirenz or lopinavir\/r based antiretroviral therapy","volume":"8","author":"Vesterbacka","year":"2013","journal-title":"PLoS One"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/tropej\/fmz022","article-title":"Immune activation and microbial translocation markers in HIV-exposed uninfected malawian infants in the first year of life","volume":"65","author":"Baroncelli","year":"2019","journal-title":"J Trop Pediatr"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210728","article-title":"Serum zonulin as a marker of intestinal mucosal barrier function: may not be what it seems","volume":"14","author":"Ajamian","year":"2019","journal-title":"PLoS One"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41581-019-0129-4","article-title":"Glycosylation in health and disease","volume":"15","author":"Reily","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108502","article-title":"HIV antibody Fc N-linked glycosylation is associated with viral rebound","volume":"33","author":"Offersen","year":"2020","journal-title":"Cell Rep"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody glycosylation in inflammation, disease and vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/glycob\/cwaa018","article-title":"Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases","volume":"30","author":"Irvine","year":"2020","journal-title":"Glycobiology"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/bp050228w","article-title":"Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro","volume":"21","author":"Hodoniczky","year":"2005","journal-title":"Biotechnol Prog"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbagen.2016.01.013","article-title":"Glycomics and glycoproteomics focused on aging and age-related diseases\u2013Glycans as a potential biomarker for physiological alterations","volume":"1860","author":"Miura","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11904-019-00433-w","article-title":"Breaking the glyco-code of HIV persistence and immunopathogenesis","volume":"16","author":"Colomb","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/gerona\/glt190","article-title":"Glycans are a novel biomarker of chronological and biological ages","volume":"69","author":"Kristic","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/gerona\/glt202","article-title":"Are glycans the Holy Grail for biomarkers of aging?","volume":"69","author":"Le Couteur","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2023032107574022700_","article-title":"Profiling IgG N-glycans as potential biomarker of chronological and biological ages: a community-based study in a Han Chinese population","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/095632020101200301","article-title":"Cytokines and HIV-1: interactions and clinical implications","volume":"12","author":"Kedzierska","year":"2001","journal-title":"Antivir Chem Chemother"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1097\/QAD.0000000000001096","article-title":"Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals","volume":"30","author":"Krebs","year":"2016","journal-title":"AIDS"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-030-12668-1_11","article-title":"Deciphering endothelial dysfunction in the HIV-infected population","volume":"1134","author":"Mezoh","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0923-2494(97)82482-0","article-title":"Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression","volume":"148","author":"Galea","year":"1997","journal-title":"Res Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3389\/fimmu.2019.01078","article-title":"Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment","volume":"10","author":"Harjunpaa","year":"2019","journal-title":"Front Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cels.2017.06.014","article-title":"Systematic investigation of multi-TLR sensing identifies regulators of sustained gene activation in macrophages","volume":"5","author":"Lin","year":"2017","journal-title":"Cell Syst"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cell.2011.09.051","article-title":"CD14 controls the LPS-induced endocytosis of Toll-like receptor 4","volume":"147","author":"Zanoni","year":"2011","journal-title":"Cell"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/bmm.11.15","article-title":"Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection","volume":"5","author":"Lichtfuss","year":"2011","journal-title":"Biomark Med"},{"key":"2023032107574022700_","article-title":"Persons who inject drugs (PWID) retain functional NK cells, dendritic cell stimulation, and adaptive immune recall responses despite prolonged opioid use","volume-title":"J Leukoc Biol","author":"Tomescu","year":"2020"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13365-011-0037-2","article-title":"Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis","volume":"17","author":"Banerjee","year":"2011","journal-title":"J Neurovirol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"E1297","DOI":"10.1073\/pnas.1422481112","article-title":"Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity","volume":"112","author":"Washburn","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/j.jmb.2014.07.006","article-title":"Structural characterization of anti-inflammatory immunoglobulin G Fc proteins","volume":"426","author":"Ahmed","year":"2014","journal-title":"J Mol Biol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s10875-010-9405-6","article-title":"A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs","volume":"30","author":"Anthony","year":"2010","journal-title":"J Clin Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1073\/pnas.0810163105","article-title":"Identification of a receptor required for the anti-inflammatory activity of IVIG","volume":"105","author":"Anthony","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20061788","article-title":"The antiinflammatory activity of IgG: the intravenous IgG paradox","volume":"204","author":"Nimmerjahn","year":"2007","journal-title":"J Exp Med"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nri2761","article-title":"Therapeutic antibodies for autoimmunity and inflammation","volume":"10","author":"Chan","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/nm.2862","article-title":"Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1","volume":"18","author":"Karsten","year":"2012","journal-title":"Nat Med"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1038\/s41467-021-24077-w","article-title":"Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV","volume":"12","author":"Giron","year":"2021","journal-title":"Nat Commun"},{"key":"2023032107574022700_","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/JLB.3HI1217-500R","article-title":"Frontline Science: plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy","volume":"104","author":"Vadrevu","year":"2018","journal-title":"J Leukoc Biol"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.4A1221-678RR","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.4A1221-678RR","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/112\/4\/733\/49471964\/jlb11201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/112\/4\/733\/49471964\/jlb11201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T06:59:06Z","timestamp":1700895546000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/112\/4\/733\/6976229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":98,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,8,2]]},"published-print":{"date-parts":[[2022,9,30]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.4a1221-678rr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10]]},"published":{"date-parts":[[2022,8,2]]},"assertion":[{"value":"2021-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}